Player FM ऐप के साथ ऑफ़लाइन जाएं!
पॉडकास्ट सुनने लायक
प्रायोजित
![<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/the-agile-brand-with-greg-kihlstromr">The Agile Brand with Greg Kihlström®</a></span> podcast artwork](https://cdn.player.fm/images/25641206/series/oilf68jgHPTH2oAn/32.jpg 32w, https://cdn.player.fm/images/25641206/series/oilf68jgHPTH2oAn/64.jpg 64w, https://cdn.player.fm/images/25641206/series/oilf68jgHPTH2oAn/128.jpg 128w, https://cdn.player.fm/images/25641206/series/oilf68jgHPTH2oAn/256.jpg 256w, https://cdn.player.fm/images/25641206/series/oilf68jgHPTH2oAn/512.jpg 512w)
![<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/the-agile-brand-with-greg-kihlstromr">The Agile Brand with Greg Kihlström®</a></span> podcast artwork](/static/images/64pixel.png)
#32 Pharmacovigilance in older adults – Giovanni Furlan
Manage episode 446781830 series 2749727
Medication-related-harm (MRH) is especially prevalent in older adults due to changing physiology as the body ages, increased frailty, and the incidence of polypharmacy in this patient group. Giovanni Furlan, Worldwide Safety Site Lead for Thessaloniki of Pfizer discusses what makes this patient group so vulnerable to adverse drug reactions, how poor representation and using age alone to define older adults exacerbates this problem, and suggests ways forward in monitoring drug safety in older patients.
Tune in to find out:
- What makes older adults especially at risk of experiencing adverse drug reactions and medication errors
- Why frailty is far more useful than age in predicting adverse drug reaction risk
- How pharmacovigilance in older patients may be improved through pharmaceutical practice and better representation in clinical trials.
Want to know more?
This interview all started with Giovanni's Uppsala Reports article on how age is insufficient a measure of adverse event risk. Read it here.
For a summary of the key points discussed in this interview, read Giovanni’s paper on the status of drug safety in geriatric patients.
If our discussion of frailty piqued your interest, read this paper on the biology of frailty and how this impacts clinical pharmacology, this multi-centre cohort study that shows frailty is significantly correlated with MRH, and this commentary advocating for consideration of MRH as a geriatric syndrome, which needs to be managed as such.
As Giovanni mentioned in the interview, Harlan Krumholz was the first to describe post-hospital syndrome. Learn more about this syndrome by reading his paper.
For more on prescribing cascades, their prevention, detection, and reversal, read this paper by Brath and colleagues.
Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.
अध्यायों
1. #32 Pharmacovigilance in older adults – Giovanni Furlan (00:00:00)
2. Introduction (00:00:15)
3. Welcome Giovanni! (00:01:22)
4. Why older adults are more at risk of experiencing adverse reactions to medicines (00:02:40)
5. Why age alone should not be used as the defining characteristic in this patient group (00:12:11)
6. Older adults are underrepresented in clinical trials and its impact on pharmacovigilance (00:15:58)
7. Post-hospital syndrome in older patients (00:24:21)
8. How pharmaceutical practice is being tailored to older patients (00:35:00)
9. What more can be done to improve pharmacovigilance in elderly patients (00:40:50)
10. Outro (00:46:43)
52 एपिसोडस
Manage episode 446781830 series 2749727
Medication-related-harm (MRH) is especially prevalent in older adults due to changing physiology as the body ages, increased frailty, and the incidence of polypharmacy in this patient group. Giovanni Furlan, Worldwide Safety Site Lead for Thessaloniki of Pfizer discusses what makes this patient group so vulnerable to adverse drug reactions, how poor representation and using age alone to define older adults exacerbates this problem, and suggests ways forward in monitoring drug safety in older patients.
Tune in to find out:
- What makes older adults especially at risk of experiencing adverse drug reactions and medication errors
- Why frailty is far more useful than age in predicting adverse drug reaction risk
- How pharmacovigilance in older patients may be improved through pharmaceutical practice and better representation in clinical trials.
Want to know more?
This interview all started with Giovanni's Uppsala Reports article on how age is insufficient a measure of adverse event risk. Read it here.
For a summary of the key points discussed in this interview, read Giovanni’s paper on the status of drug safety in geriatric patients.
If our discussion of frailty piqued your interest, read this paper on the biology of frailty and how this impacts clinical pharmacology, this multi-centre cohort study that shows frailty is significantly correlated with MRH, and this commentary advocating for consideration of MRH as a geriatric syndrome, which needs to be managed as such.
As Giovanni mentioned in the interview, Harlan Krumholz was the first to describe post-hospital syndrome. Learn more about this syndrome by reading his paper.
For more on prescribing cascades, their prevention, detection, and reversal, read this paper by Brath and colleagues.
Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.
अध्यायों
1. #32 Pharmacovigilance in older adults – Giovanni Furlan (00:00:00)
2. Introduction (00:00:15)
3. Welcome Giovanni! (00:01:22)
4. Why older adults are more at risk of experiencing adverse reactions to medicines (00:02:40)
5. Why age alone should not be used as the defining characteristic in this patient group (00:12:11)
6. Older adults are underrepresented in clinical trials and its impact on pharmacovigilance (00:15:58)
7. Post-hospital syndrome in older patients (00:24:21)
8. How pharmaceutical practice is being tailored to older patients (00:35:00)
9. What more can be done to improve pharmacovigilance in elderly patients (00:40:50)
10. Outro (00:46:43)
52 एपिसोडस
सभी एपिसोड
×![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #35 Veterinary pharmacovigilance part 2 – James Mount 41:42
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #34 Veterinary pharmacovigilance, Part I – James Mount 47:21
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias 38:43
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #32 Pharmacovigilance in older adults – Giovanni Furlan 47:51
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori 42:45
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects 25:02
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance 30:18
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #30 Preventing and reporting medication errors – Rabat CC & UMC 33:58
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #29 When medicines change our behaviour – Michele Fusaroli 30:30
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #28 Catching black swans – François Montastruc 27:21
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #27 When drugs damage the liver – Rita Baião 28:30
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #26 What's trending in pharmacovigilance? – Angela Caro 28:06
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #25 A week in the name of medicines safety – part 2 33:13
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #24 A week in the name of medicines safety – part 1 27:09
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 Uppsala Reports Long Reads – The colour of signals 33:59
प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।